These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1682287)

  • 1. [Biguanides in diabetes therapy. New aspects with special regard to the metabolic syndrome. Satellite symposium of the 2nd German Physicians' Conference. Dresden, 15 June 1991].
    Internist (Berl); 1991; 32(8 Suppl):1-12. PubMed ID: 1682287
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biguanides].
    Takahashi T; Odawara M
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():632-5. PubMed ID: 21766673
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of biguanides on the indicators of thrombelastography and the level of lactic acid in diabetes mellitus].
    Blagosklonnaia IaV; Krasil'nikova EI; Zaĭed N; Babenko AIu
    Sov Med; 1990; (12):17-20. PubMed ID: 2097752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The biguanides].
    Taurand P
    Soins; 1987 Dec; (507):I-II. PubMed ID: 3438744
    [No Abstract]   [Full Text] [Related]  

  • 5. [Circadian profiles of lactic and pyruvic acid in diabetic patients treated with biguanides and sulfonylureas].
    Cheli V; Buzzo P; Melga P; Accoto S; Prando R
    Clin Ter; 1986 Aug; 118(4):269-75. PubMed ID: 3757467
    [No Abstract]   [Full Text] [Related]  

  • 6. [Alteration of blood lactic acid levels in biguanide therapy in diabetics].
    Yang DP; Liang JZ; Luo ZT
    Sichuan Yi Xue Yuan Xue Bao; 1985 Jun; 16(2):162-5. PubMed ID: 3939266
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biguanides in oral antidiabetic therapy: indications and limitations].
    Gregorio F; Filipponi P
    Medicina (Firenze); 1988; 8(3):262-8. PubMed ID: 3231038
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sulfonylurea compounds or biguanides in the treatment of type 2 diabetes?].
    Mehnert H
    Dtsch Med Wochenschr; 1989 Jul; 114(27):1086-8. PubMed ID: 2500320
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].
    Neye H
    Pharm Unserer Zeit; 2002; 31(3):264-70. PubMed ID: 12071123
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination therapy with biguanides].
    Sakura H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():724-8. PubMed ID: 12430309
    [No Abstract]   [Full Text] [Related]  

  • 11. Biguanides enhance glucose utilization and insulin action in peripheral tissues: an old finding from the sixties of the last century.
    Schatz H
    Horm Metab Res; 2006 Oct; 38(10):690. PubMed ID: 17075781
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological treatment of type 2 diabetes.
    Hermans MP; Buysschaert M
    Acta Clin Belg; 2004; 59(2):59-66. PubMed ID: 15224468
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic utility of biguanides in the treatment of NIDDM].
    Fujimoto S
    Nihon Rinsho; 1999 Mar; 57(3):657-62. PubMed ID: 10199150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term biguanide treatment in the natural evolution of NIDDM].
    Isnard F
    Journ Annu Diabetol Hotel Dieu; 1996; ():273-88. PubMed ID: 8965430
    [No Abstract]   [Full Text] [Related]  

  • 15. [What is new about diabetes mellitus, type 2?].
    Hügl SR; Palitzsch KD
    Krankenpfl J; 1999 Jun; 37(6):223-5. PubMed ID: 10524088
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral therapy of type II diabetes].
    Haupt E; Schöffling K
    Med Klin (Munich); 1989 Apr; 84(4):203-7. PubMed ID: 2657363
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin sensitizers.
    Zangeneh F; Kudva YC; Basu A
    Mayo Clin Proc; 2003 Apr; 78(4):471-9. PubMed ID: 12683699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guidelines of the Swiss Diabetic Association concerning oral antidiabetic agents].
    Pernet A; Bäbler M; Ganz K
    Schweiz Rundsch Med Prax; 1986 May; 75(21):626-8. PubMed ID: 3726361
    [No Abstract]   [Full Text] [Related]  

  • 20. All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides.
    Mannucci E; Monami M; Masotti G; Marchionni N
    Diabetes Metab Res Rev; 2004; 20(1):44-7. PubMed ID: 14737744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.